United States
bNAbs, infant T/F virus, mother-to-child-transmission, HIV, neutralization
HIV-1, Mother-to-infant-transmission, Envelope glycoprotein, Fetus, In utero transmission, Selection signature
COVID-19, SARS-CoV-2, Hsp90, Post-exposure prophylaxis, anti-inflammatory, host directed therapy, orally bioavailable